A detailed history of Gateway Investment Advisers LLC transactions in Viatris Inc stock. As of the latest transaction made, Gateway Investment Advisers LLC holds 26,857 shares of VTRS stock, worth $278,775. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,857
Previous 21,886 22.71%
Holding current value
$278,775
Previous $237,000 35.02%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

BUY
$11.27 - $13.53 $56,023 - $67,257
4,971 Added 22.71%
26,857 $320,000
Q4 2023

Jan 09, 2024

BUY
$8.77 - $10.85 $99,574 - $123,190
11,354 Added 107.8%
21,886 $237,000
Q3 2023

Oct 19, 2023

SELL
$9.59 - $11.35 $2,244 - $2,655
-234 Reduced 2.17%
10,532 $103,000
Q2 2023

Jul 13, 2023

BUY
$9.02 - $10.29 $992 - $1,131
110 Added 1.03%
10,766 $107,000
Q1 2023

Apr 11, 2023

SELL
$9.2 - $12.26 $5,584 - $7,441
-607 Reduced 5.39%
10,656 $102,000
Q4 2022

Jan 13, 2023

BUY
$8.72 - $11.56 $98,213 - $130,200
11,263 New
11,263 $0
Q2 2022

Jul 13, 2022

SELL
$9.95 - $12.27 $10,407 - $12,834
-1,046 Reduced 7.1%
13,680 $143,000
Q1 2022

Apr 14, 2022

SELL
$9.81 - $15.4 $8,573 - $13,459
-874 Reduced 5.6%
14,726 $160,000
Q4 2021

Jan 14, 2022

SELL
$12.09 - $14.68 $3.27 Million - $3.98 Million
-270,854 Reduced 94.55%
15,600 $211,000
Q3 2021

Oct 22, 2021

SELL
$13.25 - $15.13 $514,312 - $587,286
-38,816 Reduced 11.93%
286,454 $3.88 Million
Q2 2021

Jul 13, 2021

SELL
$12.97 - $16.15 $2.54 Million - $3.16 Million
-195,752 Reduced 37.57%
325,270 $4.65 Million
Q1 2021

Apr 14, 2021

BUY
$13.59 - $18.54 $18,604 - $25,381
1,369 Added 0.26%
521,022 $7.28 Million
Q4 2020

Jan 14, 2021

BUY
$14.3 - $18.74 $7.43 Million - $9.74 Million
519,653 New
519,653 $9.74 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $12.6B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Gateway Investment Advisers LLC Portfolio

Follow Gateway Investment Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gateway Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gateway Investment Advisers LLC with notifications on news.